Michael Halassa.

Michael Halassa

Professor of neuroscience and psychiatry
Tufts University

Michael Halassa is professor of neuroscience and psychiatry at Tufts University. Hisresearch focuses on cognitive control and flexibility. His lab has identified the first non-relay function for the thalamus: the control of task-relevant prefrontal dynamics and effective connectivity. This work has opened up many new lines of research and provided fundamental insight into the neural basis of human cognition. His lab trainees have gone on to lead faculty positions at various institutions. 

Halassa is also a board-certified and practicing psychiatrist who specializes in treatment of psychotic disorders. His clinical research is focused on identifying novel precision targets based on emerging pharmacology and neurostimulation. He has been consistently funded by the U.S. National Institutes of Health and has received several fellowships and prizes throughout his career—most notably, the Vilcek Prize for Promise in the Biomedical Sciences (2017), an award given to immigrant scientists who have made extraordinary contributions to American society.

Halassa earned his Ph.D. in neuroscience at the University of Pennsylvania and his M.D. at the University of Jordan.

From this contributor

Explore more from The Transmitter

Language-responsive regions light up in red on a series of brain scans.

Cerebellum responds to language like cortical areas

One of four language-responsive cerebellar regions may encode meaningful information, much like the cortical language network in the left hemisphere, according to a new study.

By Natalia Mesa
6 February 2026 | 4 min read
Illustration of a star-nosed mole.

Neuro’s ark: Understanding fast foraging with star-nosed moles

“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.

By Lauren Schneider
4 February 2026 | 7 min read
A hand reaches to pull a sheet of paper out of a stack of papers.

Largest leucovorin-autism trial retracted

A reanalysis of the data revealed errors and failed to replicate the results.

By Claudia López Lloreda
3 February 2026 | 4 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.